National randomised controlled trial is needed

BMJ

Volumn 336, Issue 7642, 2008, Pages 461-462

  Donnelly, Peter K ^a   Hiller, Louise ^b   Dunn, Janet A ^b  

^a TORBAY AND SOUTH DEVON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANXIETY; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CANCER SURVIVOR; EMERGENCY PHYSICIAN; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE ORGANIZATION; HUMAN; LETTER; MAMMOGRAPHY; MEDICAL SPECIALIST; MORBIDITY; NURSING CARE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY CONTROL; RECURRENT DISEASE; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT DURATION; UNITED KINGDOM;

EID: 40449138005     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39500.469664.1f     Document Type: Letter

References (5)